menu
    • menu

    List of Related Excipient Companies and Suppliers of DSSTox_CID_3569 on PharmaCompass.com

    Client Email Product
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Access Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    10

    API Suppliers

    API Suppliers

    9

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    1

    EU WC

    EU WC

    0

    KDMF

    KDMF

    2

    NDC API

    NDC API

    0

    VMF

    NDC API

    2

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 18,300

    MARKET PLACE

    0

    API

    0

    FDF

    0INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    50

    FDF Dossiers

    FDF Dossiers

    42

    FDA Orange Book

    FDA (Orange Book)

    4

    Europe

    Europe

    3

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    1

    Listed Dossiers

    Listed Dossiers

    0 DRUGS IN DEVELOPMENT

    FDF DossiersDRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    1

    USP

    0

    JP

    1

    Others

    PATENTS & EXCLUSIVITIES

    0

    US Patents

    0

    US Exclusivities

    8

    Health Canada Patents

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    3

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    NA

    Annual Reports

    NA

    Finished Drug Prices

    NA

    109 RELATED EXCIPIENT COMPANIES

    183EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 155141-29-0, Avandia, Rosiglitazone (maleate), Rosiglitazone maleate [usan], Brl-49653c, Brl 49653c
    Molecular Formula
    C22H23N3O7S
    Molecular Weight
    473.5  g/mol
    InChI Key
    SUFUKZSWUHZXAV-BTJKTKAUSA-N
    FDA UNII
    KX2339DP44
    Rosiglitazone Maleate
    A thiazolidinedione that functions as a selective agonist for PPAR GAMMA. It improves INSULIN SENSITIVITY in adipose tissue, skeletal muscle, and the liver of patients with TYPE 2 DIABETES MELLITUS.
    1 2D Structure

    Rosiglitazone Maleate

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (Z)-but-2-enedioic acid;5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
    2.1.2 InChI
    InChI=1S/C18H19N3O3S.C4H4O4/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15;5-3(6)1-2-4(7)8/h2-9,15H,10-12H2,1H3,(H,20,22,23);1-2H,(H,5,6)(H,7,8)/b;2-1-
    2.1.3 InChI Key
    SUFUKZSWUHZXAV-BTJKTKAUSA-N
    2.1.4 Canonical SMILES
    CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3.C(=CC(=O)O)C(=O)O
    2.1.5 Isomeric SMILES
    CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3.C(=C\C(=O)O)\C(=O)O
    2.2 Other Identifiers
    2.2.1 UNII
    KX2339DP44
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 5-((4-(2-methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate

    2. Avandia

    3. Brl 49653

    4. Brl-49653

    5. Brl49653

    6. Rosiglitazone

    2.3.2 Depositor-Supplied Synonyms

    1. 155141-29-0

    2. Avandia

    3. Rosiglitazone (maleate)

    4. Rosiglitazone Maleate [usan]

    5. Brl-49653c

    6. Brl 49653c

    7. Rosiglitzazone Maleate

    8. 5-(4-(2-(methyl(pyridin-2-yl)amino)ethoxy)benzyl)thiazolidine-2,4-dione Maleate

    9. Brl-49653-c

    10. Nsc-717764

    11. Kx2339dp44

    12. Avandamet

    13. 2,4-thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-, (2z)-2-butenedioate (1:1)

    14. Nyracta

    15. Rosiglitazone Xr

    16. Venvia

    17. Chebi:8892

    18. Brl 49653-c

    19. (2z)-but-2-enedioic Acid; 5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione

    20. (z)-but-2-enedioic Acid;5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione

    21. 5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione Maleate

    22. Smr000471612

    23. Avandia (tn)

    24. Unii-kx2339dp44

    25. 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione Maleate

    26. 5-[4-[2-[n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione Maleate

    27. Rosiglitazonemaleate

    28. 2,4-thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (2z)-2-butenedioate (1:1)

    29. (+-)-5-(p-(2-(methyl-2-pyridylamino)ethoxy)benzyl)-2,4-thiazolidinedione Maleate (1:1)

    30. 1217260-35-9

    31. 5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione; But-2-enedioic Acid

    32. Dsstox_cid_3569

    33. Chembl843

    34. Dsstox_rid_77086

    35. Dsstox_gsid_23569

    36. Schembl19023

    37. Rosiglitazone Maleate- Bio-x

    38. Mls001306472

    39. Mls001401426

    40. Dtxsid2023569

    41. Rosiglitazone Maleate (jan/usp)

    42. Hms2051b11

    43. Hms2233i10

    44. Hms3884h04

    45. Rosiglitazone Maleate [mi]

    46. Rosiglitazone Maleate [jan]

    47. Tox21_302367

    48. Ac-737

    49. Mfcd03427306

    50. Nsc717764

    51. Rosiglitazone Maleate [vandf]

    52. S2505

    53. Rosiglitazone Maleate [mart.]

    54. Akos015961534

    55. Rosiglitazone Maleate [usp-rs]

    56. Rosiglitazone Maleate [who-dd]

    57. Ccg-100943

    58. Ccg-208126

    59. Cs-1692

    60. Ks-5027

    61. Nc00193

    62. Nsc 717764

    63. Ncgc00255233-01

    64. 5-{[4-({2-[methyl(pyridin-2-yl)amino]ethyl}oxy)phenyl]methyl}-1,3-thiazolidine-2,4-dione (2z)-but-2-enedioate

    65. Br164376

    66. Hy-14600

    67. Rosiglitazone Maleate [orange Book]

    68. Cas-155141-29-0

    69. Rosiglitazone Maleate [usp Monograph]

    70. Sw197573-4

    71. D00596

    72. Rosiglitazone Maleate 100 Microg/ml In Methanol

    73. 141r290

    74. A809615

    75. Q27888042

    76. 2, 5-[[4-[2-(methyl-2-pyridinylamino) Ethoxy]phenyl]methyl]-, (2z)-2-butenedioate (1:1)

    77. 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]phenyl Methyl]thiazolidine-2,4-dione Maleate

    78. 5-{4-[2-(methylpyridin-2-ylamino)ethoxy]benzyl}thiazolidine-2,4-dione Maleate

    79. (+/-)-5-(p-(2-(methyl-2-pyridylamino)ethoxy)benzyl)-2,4-thiazolidinedione Maleate (1:1)

    80. (z)-but-2-enedioate;2-[4-[(2,4-dioxo-1,3-thiazolidin-3-ium-5-yl)methyl]phenoxy]ethyl-methyl-pyridin-2-ylazanium

    81. 5-((4-(2-(n-methyl-n-2-pyridylamino)ethoxy)phenyl)methyl)thiazolidine-2,4-dione Maleate

    2.4 Create Date
    2005-03-26
    3 Chemical and Physical Properties
    Molecular Weight 473.5 g/mol
    Molecular Formula C22H23N3O7S
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count10
    Rotatable Bond Count9
    Exact Mass473.12567125 g/mol
    Monoisotopic Mass473.12567125 g/mol
    Topological Polar Surface Area171 Ų
    Heavy Atom Count33
    Formal Charge0
    Complexity588
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count1
    Defined Bond Stereocenter Count1
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 6  
    Drug NameAvandaryl
    PubMed HealthRosiglitazone (By mouth)
    Drug ClassesAntidiabetic
    Active Ingredientrosiglitazone maleate; Glimepiride
    Dosage FormTablet
    RouteOral
    Strength4mg; 2mg; 1mg; 8mg
    Market StatusPrescription
    CompanySb Pharmco

    2 of 6  
    Drug NameAvandia
    Drug LabelAVANDIA (rosiglitazone maleate) is an oral antidiabetic agent which acts primarily by increasing insulin sensitivity. AVANDIA improves glycemic control while reducing circulating insulin levels. Rosiglitazone maleate is not chemically or functionally...
    Active IngredientRosiglitazone maleate
    Dosage FormTablet
    RouteOral
    Strengtheq 4mg base; eq 2mg base; eq 8mg base
    Market StatusPrescription
    CompanySb Pharmco

    3 of 6  
    Drug NameRosiglitazone maleate
    PubMed HealthRosiglitazone/Glimepiride (By mouth)
    Drug ClassesAntidiabetic
    Drug LabelAVANDIA (rosiglitazone maleate) is an oral antidiabetic agent which acts primarily by increasing insulin sensitivity. AVANDIA improves glycemic control while reducing circulating insulin levels. Rosiglitazone maleate is not chemically or functionally...
    Active IngredientRosiglitazone maleate
    Dosage FormTablet
    Routeoral; Oral
    Strengtheq 4mg base; eq 2mg base; 8mg; 4mg; 2mg; eq 8mg base
    Market StatusTentative Approval; Prescription
    CompanyMylan Pharma; Teva; Sandoz; Hikma Pharms; Roxane

    4 of 6  
    Drug NameAvandaryl
    PubMed HealthRosiglitazone (By mouth)
    Drug ClassesAntidiabetic
    Active Ingredientrosiglitazone maleate; Glimepiride
    Dosage FormTablet
    RouteOral
    Strength4mg; 2mg; 1mg; 8mg
    Market StatusPrescription
    CompanySb Pharmco

    5 of 6  
    Drug NameAvandia
    Drug LabelAVANDIA (rosiglitazone maleate) is an oral antidiabetic agent which acts primarily by increasing insulin sensitivity. AVANDIA improves glycemic control while reducing circulating insulin levels. Rosiglitazone maleate is not chemically or functionally...
    Active IngredientRosiglitazone maleate
    Dosage FormTablet
    RouteOral
    Strengtheq 4mg base; eq 2mg base; eq 8mg base
    Market StatusPrescription
    CompanySb Pharmco

    6 of 6  
    Drug NameRosiglitazone maleate
    PubMed HealthRosiglitazone/Glimepiride (By mouth)
    Drug ClassesAntidiabetic
    Drug LabelAVANDIA (rosiglitazone maleate) is an oral antidiabetic agent which acts primarily by increasing insulin sensitivity. AVANDIA improves glycemic control while reducing circulating insulin levels. Rosiglitazone maleate is not chemically or functionally...
    Active IngredientRosiglitazone maleate
    Dosage FormTablet
    Routeoral; Oral
    Strengtheq 4mg base; eq 2mg base; 8mg; 4mg; 2mg; eq 8mg base
    Market StatusTentative Approval; Prescription
    CompanyMylan Pharma; Teva; Sandoz; Hikma Pharms; Roxane

    4.2 Drug Indication

    AVANDAMET is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients:

    - who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.

    - in triple oral therapy with sulphonylurea in patients with insufficient glycaemic control despite dual oral therapy with their maximally tolerated dose of metformin and a sulphonylurea (see section 4. 4).

    Rosiglitazone is indicated in the treatment of type 2 diabetes mellitus:

    as monotherapy

    -in patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance

    as dual oral therapy in combination with

    -metformin, in patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin

    -a sulphonylurea, only in patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite monotherapy with a sulphonylurea

    as triple oral therapy in combination with

    -metformin and a sulphonylurea, in patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy (see section 4. 4).

    Rosiglitazone is indicated as oral monotherapy in type 2 diabetes mellitus patients, particularly overweight patients, inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance.

    Rosiglitazone is also indicated for oral combination treatment in type 2 diabetes mellitus patients with insufficient glycaemic control despite maximal tolerated dose of oral monotherapy with either metformin or a sulphonylurea:

    - in combination with metformin particularly in overweight patients.

    - in combination with a sulphonylurea only in patients who show intolerance to metformin or for whom metformin is contraindicated.

    Rosiglitazone is indicated as oral monotherapy in type 2 diabetes mellitus patients, particularly overweight patients, inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance.

    Rosiglitazone is also indicated for oral combination treatment in type 2 diabetes mellitus patients with insufficient glycaemic control despite maximal tolerated dose of oral monotherapy with either metformin or a sulphonylurea:

    - in combination with metformin particularly in overweight patients.

    - in combination with a sulphonylurea only in patients who show intolerance to metformin or for whom metformin is contraindicated.

    Alzheimer's Disease

    5 Pharmacology and Biochemistry
    5.1 MeSH Pharmacological Classification

    Hypoglycemic Agents

    Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)

    5.2 ATC Code

    A10BD03

    A10BG02

    A10BG02

    A10BG02

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1666377000,"product":"ROSIGLITAZONE MALEATE USP (EXPORT INVOIC","address":"PLOT NO. 72, H.NO. 8-2-334\/3 & 4 ROAD NO.5, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"SMS PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"TO THE ORDER OF","customerCountry":"CANADA","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"12000","totalValueFC":"119646.3","currency":"USD","unitRateINR":984500,"date":"22-Oct-2022","totalValueINR":"9845000","totalValueInUsd":"119646.3","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"5032390","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOT NO. 72, H.NO. 8-2-334\/3 & 4 ROAD NO.5, BANJARA HILLS, Contact N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1673202600,"product":"ROSIGLITAZONE MALEATE USP","address":"PLOT NO. 72, H.NO. 8-2-334\/3 & 4 ROAD NO.5, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"SMS PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"TO THE ORDER OF.","customerCountry":"CANADA","quantity":"12.00","actualQuantity":"12","unit":"KGS","unitRateFc":"25000","totalValueFC":"300332.2","currency":"USD","unitRateINR":2046250,"date":"09-Jan-2023","totalValueINR":"24555000","totalValueInUsd":"300332.2","indian_port":"HYDERABAD AIR","hs_no":"29420090","bill_no":"6813129","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOT NO. 72, H.NO. 8-2-334\/3 & 4 ROAD NO.5, BANJARA HILLS, Contact N, HYDERABAD","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1718217000,"product":"ROSIGLITAZONE MALEATE USP RE-IMPORT REJECTED GOODS VIDE SB NO.5032390 DT.22.10.2022","address":"PLOT NO.19-III, ROAD NO.71, OPP.","city":"JUBILEE HILLS, HYDERABAD. AP","supplier":"SMS PHARMACEUTICALS LTD","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"SMS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"2.28","actualQuantity":"2.276","unit":"KGS","unitRateFc":"12000","totalValueFC":"27725.5","currency":"USD","unitRateINR":"1011600","date":"13-Jun-2024","totalValueINR":"2302401.6","totalValueInUsd":"27725.5","indian_port":"Hyderabad Air","hs_no":"29331999","bill_no":"3971026","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"TORONTO","supplierAddress":"PLOT NO.72,H NO.8-2-334\/3&4ROAD NO.5BANJARA BILLS IN","customerAddress":"PLOT NO.19-III, ROAD NO.71, OPP."}]
    22-Oct-2022
    13-Jun-2024
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    DRUG PRODUCT COMPOSITIONS

    Do you need Business Intel? Ask us

    DOSAGE - TABLET;ORAL - EQ 2MG BASE

    USFDA APPLICATION NUMBER - 21071

    read-more

    DOSAGE - TABLET;ORAL - EQ 4MG BASE

    USFDA APPLICATION NUMBER - 21071

    read-more

    DOSAGE - TABLET;ORAL - EQ 8MG BASE **Federal ...DOSAGE - TABLET;ORAL - EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    USFDA APPLICATION NUMBER - 21071

    read-more

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Fillers, Diluents & Binders

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Granulation

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Topical

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Coloring Agents

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Surfactant & Foaming Agents

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    USP

    read-more
    read-more

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search